NOVAVAX INC revenue breakdown overview

NOVAVAX INC revenue for the last year amounted to 891.25 M EUR, the most of which — 891.25 M EUR — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 1.85 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought NOVAVAX INC 891.25 M EUR, and the year before that — 1.85 B EUR.